Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

How to Peddle Hope: An Analysis of YouTube Patient Testimonials of Unproven Stem Cell Treatments.

Hawke B, Przybylo AR, Paciulli D, Caulfield T, Zarzeczny A, Master Z.

Stem Cell Reports. 2019 Jun 11;12(6):1186-1189. doi: 10.1016/j.stemcr.2019.05.009.

2.

The stem cell market and policy options: a call for clarity.

Zarzeczny A, Atkins H, Illes J, Kimmelman J, Master Z, Robillard JM, Snyder J, Turner L, Zettler PJ, Caulfield T.

J Law Biosci. 2018 Nov 20;5(3):743-758. doi: 10.1093/jlb/lsy025. eCollection 2018 Dec. No abstract available.

3.

Medical tourism and national health care systems: an institutionalist research agenda.

Béland D, Zarzeczny A.

Global Health. 2018 Jul 16;14(1):68. doi: 10.1186/s12992-018-0387-0.

4.

Research on Human Embryos and Reproductive Materials: Revisiting Canadian Law and Policy.

Ogbogu U, Zarzeczny A, Baltz J, Bedford P, Du J, Hyun I, Jaafar Y, Jurisicova A, Kleiderman E, Koukio Y, Knoppers BM, Leader A, Master Z, Nguyen MT, Noohi F, Ravitsky V, Toews M.

Healthc Policy. 2018 Feb;13(3):10-19. doi: 10.12927/hcpol.2018.25401.

5.

Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.

Murdoch B, Zarzeczny A, Caulfield T.

BMJ Open. 2018 Feb 28;8(2):e019414. doi: 10.1136/bmjopen-2017-019414.

6.

A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine.

Illes J, Sipp D, Kleiderman E, Benjaminy S, Isasi R, Lomax G, Master Z, McCormick J, Ogbogu U, Ravitsky V, Robillard JM, Rossi F, Wilson B, Zarzeczny A.

NPJ Regen Med. 2017 Jul 5;2:21. doi: 10.1038/s41536-017-0026-z. eCollection 2017. Review.

7.

Leveraging social media in the stem cell sector: exploring Twitter's potential as a vehicle for public information campaigns.

McNutt K, Zarzeczny A.

Regen Med. 2017 Oct;12(7):753-764. doi: 10.2217/rme-2017-0055. Epub 2017 Nov 8.

PMID:
29115911
8.

Wicked policy issues in regenerative medicine and the need to explore new avenues for public engagement.

Zarzeczny A, McNutt K.

Regen Med. 2017 Oct;12(7):749-752. doi: 10.2217/rme-2017-0108. Epub 2017 Nov 7. No abstract available.

PMID:
29111875
9.

Marketing of unproven stem cell-based interventions: A call to action.

Sipp D, Caulfield T, Kaye J, Barfoot J, Blackburn C, Chan S, De Luca M, Kent A, McCabe C, Munsie M, Sleeboom-Faulkner M, Sugarman J, van Zimmeren E, Zarzeczny A, Rasko JEJ.

Sci Transl Med. 2017 Jul 5;9(397). pii: eaag0426. doi: 10.1126/scitranslmed.aag0426. Review.

10.

Curbing transplant tourism: Canadian physicians and the law.

Caulfield T, Zarzeczny A.

CMAJ. 2016 Sep 20;188(13):935-936. doi: 10.1503/cmaj.160497. Epub 2016 Jun 6. No abstract available.

11.

Navigating physicians' ethical and legal duties to patients seeking unproven interventions abroad.

Snyder J, Adams K, Chen YY, Birch D, Caulfield T, Cohen IG, Crooks VA, Illes J, Zarzeczny A.

Can Fam Physician. 2015 Jul;61(7):584-6, e295-8. English, French. No abstract available.

12.

Research ethics and stem cells: Is it time to re-think current approaches to oversight?

Caulfield T, Kamenova K, Ogbogu U, Zarzeczny A, Baltz J, Benjaminy S, Cassar PA, Clark M, Isasi R, Knoppers B, Knowles L, Korbutt G, Lavery JV, Lomax GP, Master Z, McDonald M, Preto N, Toews M.

EMBO Rep. 2015 Jan;16(1):2-6. doi: 10.15252/embr.201439819. Epub 2014 Dec 4. No abstract available.

13.
14.

Professional regulation: a potentially valuable tool in responding to "stem cell tourism".

Zarzeczny A, Caulfield T, Ogbogu U, Bell P, Crooks VA, Kamenova K, Master Z, Rachul C, Snyder J, Toews M, Zoeller S.

Stem Cell Reports. 2014 Sep 9;3(3):379-84. doi: 10.1016/j.stemcr.2014.06.016. Epub 2014 Jul 31.

15.

Defining 'medical necessity' in an age of personalised medicine: A view from Canada.

Caulfield T, Zarzeczny A.

Bioessays. 2014 Sep;36(9):813-7. doi: 10.1002/bies.201400073. Epub 2014 Jul 24.

PMID:
25059840
16.

What's missing? Discussing stem cell translational research in educational information on stem cell "tourism".

Master Z, Zarzeczny A, Rachul C, Caulfield T.

J Law Med Ethics. 2013 Spring;41(1):254-68. doi: 10.1111/jlme.12017.

PMID:
23581669
17.

"Media, politics and science policy: MS and evidence from the CCSVI Trenches".

Pullman D, Zarzeczny A, Picard A.

BMC Med Ethics. 2013 Feb 12;14:6. doi: 10.1186/1472-6939-14-6.

18.

The evolution of policy issues in stem cell research: an international survey.

Caulfield T, Rachul C, Zarzeczny A.

Stem Cell Rev. 2012 Dec;8(4):1037-42. doi: 10.1007/s12015-012-9404-5.

PMID:
22851302
19.

Stem cell tourism and Canadian family physicians.

Caulfield T, Zarzeczny A; Toronto Stem Cell Working Group.

Can Fam Physician. 2012 Apr;58(4):365-8, e182-5. English, French. No abstract available.

20.

Legal liability and research ethics boards: the case of neuroimaging and incidental findings.

Zarzeczny A, Caulfield T.

Int J Law Psychiatry. 2012 Mar-Apr;35(2):137-45. doi: 10.1016/j.ijlp.2011.12.005. Epub 2012 Feb 1.

PMID:
22304986
21.

The rise of neuroskepticism.

Rachul C, Zarzeczny A.

Int J Law Psychiatry. 2012 Mar-Apr;35(2):77-81. doi: 10.1016/j.ijlp.2011.12.008. Epub 2012 Jan 20.

PMID:
22261321
22.

Stem cell clinics in the news.

Zarzeczny A, Rachul C, Nisbet M, Caulfield T.

Nat Biotechnol. 2010 Dec;28(12):1243-6. doi: 10.1038/nbt1210-1243b. No abstract available.

PMID:
21139603
23.

Popular culture representations of science: views from the Canadian stem cell research community.

Caulfield T, Zarzeczny A.

Stem Cell Rev. 2010 Sep;6(3):337-9. doi: 10.1007/s12015-010-9164-z. Review. No abstract available.

PMID:
20535646
24.

Stem cell tourism and doctors' duties to minors--a view from Canada.

Zarzeczny A, Caulfield T.

Am J Bioeth. 2010 May;10(5):3-15. doi: 10.1080/15265161003702865.

PMID:
20461636
25.

Stem cell research policy and iPS cells.

Caulfield T, Scott C, Hyun I, Lovell-Badge R, Kato K, Zarzeczny A.

Nat Methods. 2010 Jan;7(1):28-33. doi: 10.1038/nmeth.f.282. No abstract available.

PMID:
20038953
26.

iPS cells: mapping the policy issues.

Zarzeczny A, Scott C, Hyun I, Bennett J, Chandler J, Chargé S, Heine H, Isasi R, Kato K, Lovell-Badge R, McNagny K, Pei D, Rossant J, Surani A, Taylor PL, Ogbogu U, Caulfield T.

Cell. 2009 Dec 11;139(6):1032-7. doi: 10.1016/j.cell.2009.11.039.

27.

Emerging ethical, legal and social issues associated with stem cell research & and the current role of the moral status of the embryo.

Zarzeczny A, Caulfield T.

Stem Cell Rev. 2009 Jun;5(2):96-101. doi: 10.1007/s12015-009-9062-4. Epub 2009 May 14. Review.

PMID:
19521800
28.

The stem cell research environment: a patchwork of patchworks.

Caulfield T, Zarzeczny A, McCormick J, Bubela T, Critchley C, Einsiedel E, Galipeau J, Harmon S, Huynh M, Hyun I, Illes J, Isasi R, Joly Y, Laurie G, Lomax G, Longstaff H, McDonald M, Murdoch C, Ogbogu U, Owen-Smith J, Pattinson S, Premji S, von Tigerstrom B, Winickoff DE.

Stem Cell Rev. 2009 Jun;5(2):82-8. doi: 10.1007/s12015-009-9071-3. Epub 2009 May 27. Review.

PMID:
19521798

Supplemental Content

Loading ...
Support Center